Ten insulin pump users with type 1 diabetes ( mean age , 46.48.5 years ) were enrolled in a two-center ( in the United States and Italy ) randomized crossover trial comparing 5 consecutive nights of CLC ( 23:00 -07:00 h ) in an outpatient setting versus sensor-augmented insulin pump therapy of the same duration at home .